Stiftung Prostatakrebsforschung
Company Overview
Management
Franz Recker
Zuoz
Chairperson of the foundation board
Joint signing authority (any two to sign)
Felix Overbeck
München, DE
Member of the foundation board
Joint signing authority (any two to sign)
Maciej Kwiatkowski
Suhr
Member of the foundation board + general manager
Joint signing authority (any two to sign)
Udo Kalweit
Gontenschwil
Chairperson of the foundation board
Individual signing authority
Markus Dubs
Gossau ZH
Member of the foundation board
Without signing authority
Thomas Gasser
Liestal
Member of the foundation board
Without signing authority
Reto Tscholl
Erlinsbach
Member of the foundation board
Without signing authority
Gilbert Wenzel
Küsnacht
Member of the foundation board
Without signing authority
Thomas-Johann Lautenschlager
Liestal
General manager
Joint signing authority (any two to sign)
Maciej Kwiatkowski
Suhr
General manager
Joint signing authority (any two to sign)
Udo Kalweit
Menziken
Chairperson of the foundation board
Individual signing authority
Franz Recker
Zug
Member of the foundation board
Joint signing authority (any two to sign)
Udo Kalweit
Lenzburg
Chairperson of the foundation board
Individual signing authority
Building smart people network graph...
Fetching people and their companies
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 15237 | 15.11.2022 | 225 | 18.11.2022 | 1005608028 |
| 2 | 13596 | 07.10.2022 | 198 | 12.10.2022 | 1005581686 |
| 3 | 3028 | 05.03.2021 | 48 | 10.03.2021 | 1005120427 |
| 4 | 5680 | 06.06.2018 | 110 | 11.06.2018 | 4281701 |
| 5 | 8866 | 16.09.2015 | 182 | 21.09.2015 | 2383213 |
| 6 | 1188 | 31.01.2013 | 24 | 05.02.2013 | 7050066 |
| 7 | 3413 | 11.04.2011 | 74 | 14.04.2011 | 6121668 |
| 8 | 1556 | 11.02.2011 | 34 | 17.02.2011 | 2/6037938 |
| 9 | 5915 | 10.07.2006 | 135 | 14.07.2006 | 3/3466756 |
| 10 | 9118 | 15.12.2003 | 245 | 19.12.2003 | 3/2039384 |
Company Purpose
Förderung der klinischen Forschung bei benignen und malignen Prostatakrebserkrankungen, insbeondere in Prävention, Diagnostik und Therapie; Eingeschlossen sind auch urologisch-epidemiologische Fragestellungen sowie die Verbreitung von gesichertem urologischem Wissen (Publikationen, Kongresse, Klausuren, etc.).